https://www.youtube.com/watch?v=txaqxJycyP8 India is the third largest innovation ecosystem in the world. From India’s transformational growth in the IT sector to her rapid digitisation, innovation is truly having its moment in India today. However, despite this promising outlook, social innovation continues to face challenges to scale. Faced by
https://open.spotify.com/episode/5rsqLW3phlu3XLRgX1kteg Globally, universal health coverage (UHC) has been highlighted as an important goal, because of its close links to poverty reduction and potential to enhance the economic growth of countries. From public to private health care, across primary, secondary, and tertiary care, and whether we look at the challenges and
Understanding the Evolving Financing Needs of Farmer Producer Organizations (FPOs): From Pre-Incubation to Maturity Understanding the Evolving Financing Needs of Farmer Producer Organizations (FPOs): From Pre-Incubation to Maturity Understanding the Evolving Financing Needs of Farmer Producer Organizations (FPOs): From Pre-Incubation to Maturity The growth and success of farmer producer organisations
There is no excerpt because this is a protected post.
Ed-tech in under-resourced communities differs from typical market-based products, and argues for thoughtful design and customisation of those products.
The Sattva Partner Network recently hosted the webinar, Digital Marketing and Branding for Non-profits to guide organisations on strong brand positioning as well as the tools, steps and strategies in creating a brand.
Sattva undertook a research study commissioned by Kamonohashi Project (Kamo) to develop a report on the Anti-Human Trafficking (AHT) solution ecosystem in India.
By fostering innovations in education and skill development, the CSR programme aims to empower India’s youth and drive social transformation through technology.
Pharmaceutical production in India has been a formidable force for healthcare, so much so that no written report ever fails to eulogise India as the “pharmacy of the world”. Despite the prowess of Indian pharmaceutical industries in manufacturing affordable generic medicines, poor quality and unavailability of essential drugs, vaccines, and
How industrial companies price, manage, and report carbon risk